This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
The company uses iPS cells to develop treatments for diseases relating to the kidney
Product basket comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Aims to achieve CDMO sales of US$ 400 million by 2028
He holds a Master’s in Management from the National University of Singapore
The inspection concluded with the issuance of a form 483 with five observations
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
Subscribe To Our Newsletter & Stay Updated
